Kaposi’s Sarcoma: Demographic and Clinical Features, Histopathology, Treatment, and Outcomes in a 10-Year Lisbon Hospital Study
DOI:
https://doi.org/10.20344/amp.17991Keywords:
Sarcoma, Kaposi/diagnosis, Sarcoma, Kaposi/epidemiology, Sarcoma, Kaposi/pathology, Sarcoma, Kaposi/therapyAbstract
Introduction: Kaposi’s sarcoma (KS) is a rare angioproliferative neoplasm associated with human herpesvirus 8 infection, presenting as four subtypes: classic, endemic, iatrogenic, and epidemic. While well documented globally, comprehensive data on KS in Portugal remain scarce. The aim of this retrospective study was to provide a detailed analysis of KS cases diagnosed at Hospital Santa Maria, in Lisbon, between 2014 and 2023.
Methods: A total of 113 histopathologically confirmed KS cases were included, focusing on demographic, clinical, and histopathological characteristics, as well as treatment strategies and outcomes.
Results: The mean age at diagnosis was 59.4 years, with a male-to-female ratio of 4.4:1. Most patients (50.4%) were of African origin. Epidemic KS (45.1%) was the most prevalent subtype. Lesions mainly affected the lower limbs (47.8%), and disseminated, mucosal, and extracutaneous involvement were more common in HIV-positive patients. Tumor-stage lesions were frequent (59.3%). Single-modality treatment was used in 53.1% of cases, while 40.7% required combined therapies. Relapse rates were highest in endemic (39.1%) and iatrogenic KS (28.6%) subtypes. The disease-specific mortality rate was 8%.
Conclusion: Our findings suggest that KS remains a significant concern, particularly in immunosuppressed patients. Early diagnosis and multidisciplinary management are essential to improve outcomes. However, limitations such as potential biases from its retrospective design and the single-center scope should be considered.
Downloads
References
Curtiss P, Strazzulla LC, Friedman-Kien AE. An update on kaposi’s sarcoma: epidemiology, pathogenesis, and treatment. Dermatol Ther. 2016;6:465-70. DOI: https://doi.org/10.1007/s13555-016-0152-3
Kaposi M. Idiopathisches multiples pigmentsarkon der Haut. Arch Dermatol Syph. 1872;4:265-73. DOI: https://doi.org/10.1007/BF01830024
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated kaposi’s sarcoma. Science. 1994;266:18659. DOI: https://doi.org/10.1126/science.7997879
Grabar S, Costagliola D. Epidemiology of kaposi’s sarcoma. Cancers. 2021;13:5692. DOI: https://doi.org/10.3390/cancers13225692
Etemad SA, Dewan AK. Kaposi sarcoma updates. Dermatol Clin. 2019;37:505-17. DOI: https://doi.org/10.1016/j.det.2019.05.008
Ruocco E, Ruocco V, Tornesello ML, Gambardella A, Wolf R, Buonaguro FM. Kaposi’s sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies. Clin Dermatol. 2013;31:413-22. DOI: https://doi.org/10.1016/j.clindermatol.2013.01.008
Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, et al. Update on kaposi’s sarcoma and other HHV8-associated diseases. part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis. 2002;2:281-92. DOI: https://doi.org/10.1016/S1473-3099(02)00263-3
Mansinho M, Macedo D, Nunes B, Fernandes I, Jorge M, Borges-Costa J. Abordagem terapêutica do sarcoma de kaposi—a importância da multidisciplinaridade. Port J Dermatol Venereol. 2015;73:199-208. DOI: https://doi.org/10.29021/spdv.73.2.366
Junger J. Estudo dos doentes com sarcoma de kaposi após a introdução da terapêutica HAART nos últimos 19 anos no Hospital de Santa Maria – Lisboa (1994-2012). Lisboa: Universidade de Lisboa; 2013.
Resende C, Azevedo T, Henriques A, Calima Z, Oliveira P, Vale E, et al. Kaposi’s sarcoma—a clinicopathological review. J Port Soc Dermatol Venereol. 2015;72:471-8. DOI: https://doi.org/10.29021/spdv.72.4.316
Calvão da Silva JC, Cardoso JC, Vieira R. Kaposi’s sarcoma: a single-center experience on 38 patients. An Bras Dermatol. 2021;96:630-3. DOI: https://doi.org/10.1016/j.abd.2021.02.007
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74. DOI: https://doi.org/10.2307/2529310
Fu L, Tian T, Wang B, Lu Z, Gao Y, Sun Y, et al. Global patterns and trends in kaposi sarcoma incidence: a population-based study. Lancet Glob Health. 2023;11:e1566-75. DOI: https://doi.org/10.1016/S2214-109X(23)00349-2
Stiller CA, Botta L, Sánchez Perez MJ, Peris-Bonet R, Marcos-Gragera R, Ardanaz E, et al. kaposi sarcoma incidence, survival and trends: data from the information network on rare cancers in Europe (RARECAREnet). Cancer Epidemiol. 2021;70:101877. DOI: https://doi.org/10.1016/j.canep.2020.101877
Russo I, Marino D, Cozzolino C, Gambardella A, Salvatore D, Buonaguro FM. Kaposi’s sarcoma: evaluation of clinical features, treatment outcomes, and prognosis in a single-center retrospective case series. Cancers. 2024;16:691. DOI: https://doi.org/10.3390/cancers16040691
Yazici S, Zorlu O, Bulbul Baskan E, Balaban Adim S, Aydogan K, Saricaoglu H. Retrospective analysis of 91 kaposi’s sarcoma cases: a single-center experience and review of the literature. Dermatology. 2018;234:205-13. DOI: https://doi.org/10.1159/000492112
Su Ö, Onsun N, Arda H, Büyükbabani N, Türel-Ermertcan A, Öztürkcan S. Clinical features, presence of human herpesvirus-8 and treatment results in classic kaposi sarcoma. Arch Turk Dermatol Venereol. 2008;42:122-6.
Mirandola L, Wade R, Verma R, Jenkins MR, Peter M, Cobos E, et al. Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium. Int Rev Immunol. 2015;34:134-42. DOI: https://doi.org/10.3109/08830185.2015.1018417
Liu Z, Fang Q, Zuo J, Minhas V, Wood C, Zhang T. The worldwide incidence of kaposi’s sarcoma in the HIV/AIDS Era. HIV Med. 2018;19:355-64. DOI: https://doi.org/10.1111/hiv.12584
Motlhale M, Sitas F, Bradshaw D, Somdyala NI, Wabinga H, Chokunonga E, et al. Epidemiology of Kaposi’s sarcoma in Sub-Saharan Africa. Cancer Epidemiol. 2022;78:102167. DOI: https://doi.org/10.1016/j.canep.2022.102167
Shaaban AN, Martins MR. The importance of improving the quality of care among HIV/AIDS hospitalizations in Portugal. Front Public Health. 2019;7:266. DOI: https://doi.org/10.3389/fpubh.2019.00266
Wu XJ, Pu XM, Kang XJ, Zhang GQ, Yang SJ, Li YJ, et al. One hundred and five kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China. J Eur Acad Dermatol Venereol. 2014;28:1545-52. DOI: https://doi.org/10.1111/jdv.12349
Tiussi RM, Caus AL, Diniz LM, Lucas EA. Kaposi’s sarcoma: clinical and pathological aspects in patients seen at the Hospital Universitário Cassiano Antônio Moraes—Vitória—Espírito Santo—Brazil. An Bras Dermatol. 2012;87:220-7. DOI: https://doi.org/10.1590/S0365-05962012000200005
Dinh S, Malmström S, Möller IK, Yilmaz A, Svedhem V, Carlander C. Extracutaneous kaposi sarcoma risk remains higher in people with HIV in the post-ART era. AIDS. 2023;37:2041-8. DOI: https://doi.org/10.1097/QAD.0000000000003658
Pires CA, Noronha MA, Monteiro JC, Costa AL, Abreu Júnior JM. Kaposi’s sarcoma in persons living with HIV/AIDS: a case series in a tertiary referral hospital. An Bras Dermatol. 2018;93:524-8. DOI: https://doi.org/10.1590/abd1806-4841.20186978
Yanik EL, Achenbach CJ, Gopal S, Coghill AE, Cole SR, Eron JJ, et al. Changes in clinical context for kaposi’s sarcoma and non-hodgkin lymphoma among people with HIV infection in the United States. J Clin Oncol. 2016;34:3276-83. DOI: https://doi.org/10.1200/JCO.2016.67.6999
Gervas R, Mgaya E. Histopathological patterns and topographical distribution of kaposi sarcoma at Muhimbili National Hospital, Tanzania. Afr Health Sci. 2021;21:1733-8. DOI: https://doi.org/10.4314/ahs.v21i4.29
Grayson W, Pantanowitz L. Histological variants of cutaneous kaposi sarcoma. Diagn Pathol. 2008;3:31. DOI: https://doi.org/10.1186/1746-1596-3-31
Lebbe C, Garbe C, Stratigos AJ, Harwood C, Peris K, Marmol VD, et al. Diagnosis and treatment of kaposi’s sarcoma: european consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J Cancer. 2019;114:117-27. DOI: https://doi.org/10.1016/j.ejca.2018.12.036
Delyon J, Rabate C, Euvrard S, Harwood CA, Proby C, Güleç AT, et al. Management of kaposi sarcoma after solid organ transplantation: a european retrospective study. J Am Acad Dermatol. 2019;81:448-55. DOI: https://doi.org/10.1016/j.jaad.2019.03.028
Patel R, Lurain K, Yarchoan R, Ramaswami R. Clinical management of kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies. Expert Rev Anti-Infect Ther. 2023;21:929-41. DOI: https://doi.org/10.1080/14787210.2023.2247161
Zeinaty PE, Lebbé C, Delyon J. Endemic kaposi’s sarcoma. Cancers. 2023;15:872. DOI: https://doi.org/10.3390/cancers15030872
Saowapa S, Polpichai N, Siladech P, Wannaphut C, Tanariyakul M, Wattanachayakul P, et al. Evaluating kaposi sarcoma in kidney transplant patients: a systematic review and meta-analysis. Cureus. 2024;16:e52527. DOI: https://doi.org/10.7759/cureus.52527
Marcoval J, Bonfill-Ortí M, Martínez-Molina L, Valentí-Medina F, Penín RM, Servitje O. Evolution of kaposi sarcoma in the past 30 years in a tertiary hospital of the European Mediterranean basin. Clin Exp Dermatol. 2019;44:32-9. DOI: https://doi.org/10.1111/ced.13605
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
